← Evidence map

ArticleAmerican journal of nephrology2026

Effects of Sacubitril/Valsartan versus Irbesartan on Urine Tubular Biomarkers in Chronic Kidney Disease: Findings from the UK HARP-III Trial.

Michelle A Goonasekera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Effects of Sacubitril/Valsartan versus Irbesartan on Urine Tubular Biomarkers in Chronic Kidney Disease: Findings from the UK HARP-III Trial. | OpenQuestion